دورية أكاديمية
664P Final results from phase I trial of cabozantinib/nivolumab (CaboNivo) alone or with ipilimumab (CaboNivoIpi) and peripheral immunity in metastatic genitourinary (mGU) tumors
| العنوان: | 664P Final results from phase I trial of cabozantinib/nivolumab (CaboNivo) alone or with ipilimumab (CaboNivoIpi) and peripheral immunity in metastatic genitourinary (mGU) tumors |
|---|---|
| المؤلفون: | Kydd, A.R., Lee, M-J., Lee, S., Rastogi, S., Sato, N., Cordes, L., Ley, L., Sierra Ortiz, O., Wright, J.J., Streicher, H., Steinberg, S., Saraiya, B., Pal, S.K., Lara, P.N., Mortazavi, A., Costello, R., Niglio, S., Bottaro, D., Trepel, J., Apolo, A.B. |
| المصدر: | Annals of Oncology ; volume 32, page S690 ; ISSN 0923-7534 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2021 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Oncology, Hematology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.annonc.2021.08.060 |
| الإتاحة: | https://doi.org/10.1016/j.annonc.2021.08.060Test https://api.elsevier.com/content/article/PII:S0923753421022742?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S0923753421022742?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://www.elsevier.com/open-access/userlicense/1.0Test/ |
| رقم الانضمام: | edsbas.1733892A |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.annonc.2021.08.060 |
|---|